Identification of Human Presequence Protease (hPreP) Agonists for the Treatment of Alzheimer's Disease

European Journal of Medicinal Chemistry - France
doi 10.1016/j.ejmech.2014.02.046
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

The Future of Alzheimer's Disease Treatment

Aging Health
2006English

PPARγ Agonists as Therapeutics for the Treatment of Alzheimer’s Disease

Neurotherapeutics
NeurologyPharmacology
2008English

Modulation of Gamma-Secretase for the Treatment of Alzheimer's Disease

International Journal of Alzheimer's Disease
AgingCognitive NeuroscienceMolecular NeuroscienceNeurologyBehavioral NeuroscienceCellular
2012English

Will Europe Be Ready for the Treatment of Alzheimer's Disease?

The Lancet Neurology
Neurology
2018English

Potential Repurposing of Oncology Drugs for the Treatment of Alzheimer's Disease

BMC Medicine
Medicine
2013English

Recent Tau-Targeted Clinical Strategies for the Treatment of Alzheimer's Disease

Future Medicinal Chemistry
Drug DiscoveryMolecular MedicinePharmacology
2019English

Lack of Support for Bexarotene as a Treatment for Alzheimer's Disease

Neuropharmacology
Molecular NeuroscienceCellularPharmacology
2016English

A Systematic Review of Single Chinese Herbs for Alzheimer's Disease Treatment

Evidence-based Complementary and Alternative Medicine
Alternative MedicineComplementary
2011English

Treatment and Management of the Elderly Patients With Alzheimer's Disease

Nihon Ika Daigaku Igakkai Zasshi
2006English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy